BioCryst Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 22.10 M | $166.16 M | 5.64% | 10.68% |
| VANGUARD GROUP INC | 02/11/2025 | 21.89 M | $164.62 M | 7.80% | 10.58% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 11.87 M | $89.22 M | 0.00% | 5.73% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 9.09 M | $68.32 M | 0.00% | 4.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 8.14 M | $61.25 M | 0.11% | 3.94% |
| STATE STREET CORP | 02/14/2025 | 7.50 M | $56.39 M | -15.26% | 3.62% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 7.09 M | $53.35 M | 0.00% | 3.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 4.82 M | $36.28 M | -0.29% | 2.33% |
| RP MANAGEMENT, LLC | 02/03/2025 | 3.85 M | $29.23 M | 0.00% | 1.86% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 3.42 M | $25.71 M | -28.99% | 1.65% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 3.18 M | $23.93 M | -4.66% | 1.54% |
| CALIGAN PARTNERS LP | 02/14/2025 | 3.00 M | $22.53 M | 15.96% | 1.45% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 2.94 M | $22.12 M | -10.26% | 1.42% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 2.68 M | $20.14 M | -26.07% | 1.29% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 2.50 M | $18.80 M | 14.62% | 1.21% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 2.08 M | $15.65 M | -3.81% | 1.01% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 1.98 M | $14.89 M | 269.87% | 0.96% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.98 M | $14.89 M | 4.87% | 0.96% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 1.84 M | $13.86 M | -0.02% | 0.89% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.77 M | $13.34 M | 0.76% | 0.86% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 1.72 M | $12.94 M | -2.93% | 0.83% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 1.58 M | $11.88 M | -11.88% | 0.76% |
| SEGALL BRYANT & HAMILL, LLC | 02/11/2025 | 1.42 M | $10.69 M | -4.57% | 0.69% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 1.38 M | $10.41 M | 15.96% | 0.67% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.29 M | $9.71 M | -44.36% | 0.62% |
| JUPITER ASSET MANAGEMENT LTD | 02/10/2025 | 1.18 M | $8.86 M | 10.10% | 0.57% |
| INVESCO LTD. | 02/13/2025 | 1.07 M | $8.07 M | 6.71% | 0.52% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 983,033 | $7.39 M | 10.15% | 0.48% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 839,274 | $6.31 M | 6.61% | 0.41% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 835,972 | $6.29 M | 23.61% | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 800,000 | $6.02 M | 0.00% | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 790,105 | $5.94 M | -40.27% | 0.38% |
| FMR LLC | 02/13/2025 | 777,268 | $5.85 M | -60.91% | 0.38% |
| ALGERT GLOBAL LLC | 02/14/2025 | 725,305 | $5.45 M | 40.51% | 0.35% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 667,000 | $5.02 M | 0.00% | 0.32% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 633,864 | $4.77 M | -7.10% | 0.31% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 625,905 | $4.71 M | -29.18% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 596,938 | $4.49 M | 0.02% | 0.29% |
| JANE STREET GROUP, LLC | 02/14/2025 | 572,346 | $4.30 M | -19.55% | 0.28% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 565,215 | $4.25 M | -4.76% | 0.27% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 545,021 | $4.10 M | -7.48% | 0.26% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/11/2025 | 542,100 | $4.08 M | 65,213.25% | 0.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 02/14/2025 | 535,558 | $4.03 M | 0.00% | 0.26% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 529,653 | $3.98 M | 100.00% | 0.26% |
| NORGES BANK | 02/12/2025 | 524,804 | $3.95 M | 100.00% | 0.25% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 522,657 | $3.94 M | 523.92% | 0.25% |
| PDT PARTNERS, LLC | 02/14/2025 | 522,290 | $3.93 M | 0.00% | 0.25% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 519,217 | $3.90 M | 12.74% | 0.25% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 494,356 | $3.72 M | -43.89% | 0.24% |
| JPMORGAN CHASE & CO | 02/12/2025 | 474,376 | $3.57 M | -17.80% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioCryst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 325 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 22.1 M
VANGUARD GROUP INC: 21.89 M
Avoro Capital Advisors LLC: 11.87 M
Kynam Capital Management, LP: 9.09 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 8.14 M
STATE STREET CORP: 7.5 M
81.02% of BioCryst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 203.61 M shares in the last 24 months. This purchase volume represents approximately $1.59 B in transactions.